Table 1. Baseline Characteristics of Patients (N = 27) and Cord Blood Units.
| Characteristic | No. of Cases | Percent |
|---|---|---|
| Median age, yr (range) | 48 (19-67) | |
| Patient sex | ||
| Male | 14 | 51.9 |
| Female | 13 | 48.1 |
| Diagnosis | ||
| AML | 7 | 25.9 |
| CLL, SLL, PLL | 1 | 3.7 |
| CML | 1 | 3.7 |
| HL | 5 | 18.5 |
| ALL | 1 | 3.7 |
| MDS | 2 | 7.4 |
| MPD | 1 | 3.7 |
| NHL | 8 | 29.6 |
| Other acute leukemia | 1 | 3.7 |
| Disease Risk Index | ||
| Low | 2 | 7.4 |
| Intermediate | 19 | 70.4 |
| High | 6 | 22.2 |
| HLA match at A, B, DRB1 | ||
| 4/6 + 4/6 | 17 | 63.0 |
| 5/6 + 4/6 | 6 | 22.2 |
| 5/6 + 5/6 | 4 | 14.8 |
Median follow up among survivors 74 months (range 59-101).
AML indicates acute myelogenous leukemia; CLL, chronic lymphocytic leukemia; SLL, small lymphocytic lymphoma; PLL, prolymphocytic leukemia; CML, chronic myelogenous leukemia; ALL, acute lymphocytic leukemia; MDS, myelodysplastic syndrome; MPD, myeloproliferative neoplasm; HL, Hodgkin's lymphoma; NHL, non-Hodgkin lymphoma.